Foster & Motley Inc. raised its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 0.6% during the third quarter, according to its most recent filing with the SEC. The firm owned 73,925 shares of the company’s stock after purchasing an additional 436 shares during the period. Procter & Gamble accounts for approximately 0.8% of Foster & Motley Inc.’s portfolio, making the stock its 23rd largest position. Foster & Motley Inc.’s holdings in Procter & Gamble were worth $12,804,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble in the second quarter worth $29,000. Ruedi Wealth Management Inc. increased its stake in Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble during the second quarter valued at about $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble during the 2nd quarter worth about $36,000. 65.77% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Jon R. Moeller sold 72,174 shares of the firm’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 385,771 shares of company stock valued at $65,610,975. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the company earned $1.83 EPS. Procter & Gamble’s revenue for the quarter was down .6% on a year-over-year basis. Research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.43%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on PG. Evercore ISI raised their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Piper Sandler initiated coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Stifel Nicolaus upped their target price on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Thursday, August 29th. Finally, Citigroup boosted their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.
Read Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Why Invest in 5G? How to Invest in 5G Stocks
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- EV Stocks and How to Profit from Them
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Investing In Automotive Stocks
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.